Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

2
Delayed Quote. Delayed London Stock Exchange - 12/19 11:35:15 am
47.5 GBp   -4.52%
17h ago VERNALIS : Says Novartis Stops Development Work On AUY922
18h ago VERNALIS : Update on AUY922 development programme
19h ago VERNALIS : Update on AUY922 Development Programme
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
48.75(c) 48.75(c) 49(c) 49.75(c) 47.5(c) Last
65 955 1 447 25 783 634 192 284 636 Volume
-3.47% 0.00% +0.51% +1.53% -4.52% Change
More quotes
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
More about the company
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 9,80 M
EBIT 2014 -
Net income 2014 -
Finance 2014 58,1 M
Yield 2014 -
Sales 2015 13,0 M
EBIT 2015 -
Net income 2015 -
Finance 2015 28,4 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 16,5x
EV / Sales 2015 14,7x
Capitalization 220 M
More Financials
Latest news on VERNALIS PLC
17h ago VERNALIS : Says Novartis Stops Development Work On AUY922
18h ago VERNALIS : Update on AUY922 development programme
19h ago VERNALIS : Update on AUY922 Development Programme
11/28 VERNALIS : Total Voting Rights
11/18 VERNALIS : Moves Year End To Align With US Cough Cold Season
11/18 VERNALIS : Change of Year End & Commercial Business Update
11/18 VERNALIS : Change of Year-End and Commercial Business Update
10/28 VERNALIS : Third Product in Vernalis’ Cough Cold Pipeline (CCP-08) Achieve..
More news
Sector news
8h ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
10h ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
13h ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF